Efficacy and Safety of Preemptive Intravenous Dexamethasone in MIS-TLIF

Recruiting now · Phase 4

Conditions studied: Spinal Stenosis Lumbar, Disc Degeneration, Disc Disease, Fusion of Spine, Surgery

In brief

Researchers are considering Dexamethasone as preemptive medication before minimally invasive spine fusion surgery to minimize postoperative back pain with minimal side effects, aiming to enhance the effectiveness of surgery and improve patient outcomes.

Key facts

Study ID

NCT06367855

Run by

Potsawat Surabotsopon

People needed

60

Starts

2024-05-01

Expected to finish

2025-12-31

Last updated by the study team

2025-09-08

Who can join

Age: 50 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age range: 50-80 years old.
• Undergoing MIS TLIF surgery at 1-2 spinal levels.

You may not qualify if…

• Previously undergone spine surgery.
• HbA1C greater than or equal to 7.5 mg%
• Allergic to all types of experimental medication.
• History of using systemic steroids.

Where it is running

• Thammasat university hospital — Pathum Thani, Changwat Pathum Thani, Thailand (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.